Stock screener

HBIO

Conviction 56IndustrialsScan · Mon, Aug 10, 2026
HBIO$6.59+1.85%
ResistanceSupportVol 14
63 bars
Vol MA14 11.39K
May 11May 28Jun 16Jul 6Jul 23Aug 10
HARVARD BIOSCIENCE INCLABORATORY ANALYTICAL INSTRUMENTSwww.harvardbioscience.com
Price6.59
Change+1.85%
Gap-1.08%
Rel volume1.64×
Avg volume12.51K
Avg $ vol77.24K
SMA 206.15
SMA 506.16
SMA 2003.32
Price vs 50+6.93%
Price vs 200+98.28%
MA stackbullish
50/200 cross
Supertrendup · 5.71
RSI (14)62
MACD hist0.05
MACD crossbull · 5d
Stoch %K / %D94 / 82
ADX (14)24
+DI / −DI20 / 12
RSI divergence
MACD divergence
ATR %+4.18%
ADR %3.99%
52w high7.24
52w low0.3793
From 52w high-8.98%
Above 52w low+1637.41%
New 52w highNo
SqueezeOn · 36d
Bollinger width11.54%
%B1.11
Donchian pos94.52%
Donchian high6.63
Donchian low5.90
AVWAP (52w high)6.13
vs AVWAP high+7.54%
AVWAP (52w low)0.7145
vs AVWAP low+822.28%
OBV trendFlat
Chaikin MF (20)0.05
Today vs 20d1.64×
Avg vol (14d)11.39K
Avg vol (20d)12.51K
Avg $ vol (20d)77.24K
Market cap29.72M
RS 3m (vs SPY)-10.41%
RS 6m (vs SPY)+1256.65%
RS line new highNo
Trend template7/8
Technical rank91.2
1 week+4.44%
1 month+7.33%
3 months-4.42%
6 months+1230.78%
1 year+1181.85%
YTD+910.89%
P/E-0.52
P/B2.96
P/S0.34
P/FCF5.43
EPS-1.28
Div yield
ROE-564.40%
ROA-72.75%
Debt/Eq3.60
Current1.99
EV/EBITDA-1.33
Gross margin57.67%
Net margin-65.51%
Rev growth-8.06%
EPS growth-357.07%
Price target
Target upside
Analyst rating
Institutional
Ent. value58.84M
Revenue20.75M
Net income-3.42M
Gross profit12.24M
Free cash flow5.47M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out4.51M
Employees339
ListedThu, Dec 7, 2000
Free float3.35M
Float %74.3%
Short interest56.02K
Days to cover4.3d
Short volume44.2%
Squeeze score37 / 100
Next earningsTue, Aug 11, 2026 · pre-mkt (1d)
EPS forecast
Last EPS vs est
Last surprise
Setup gradeC
Conviction56 / 100
Pattern quality
Tech rank91.2 / 100
Group rank68 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance6.52
Support5.79
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in HBIO

All disclosures →
No recent disclosed trades by Congress in HBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in HBIO

No recent insider (Form 4) filings in HBIO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in HBIO · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.